391 related articles for article (PubMed ID: 31254442)
1. Detection of mutational patterns in cell-free DNA of colorectal cancer by custom amplicon sequencing.
Herrmann S; Zhan T; Betge J; Rauscher B; Belle S; Gutting T; Schulte N; Jesenofsky R; Härtel N; Gaiser T; Hofheinz RD; Ebert MP; Boutros M
Mol Oncol; 2019 Aug; 13(8):1669-1683. PubMed ID: 31254442
[TBL] [Abstract][Full Text] [Related]
2. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
[TBL] [Abstract][Full Text] [Related]
3. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
[No Abstract] [Full Text] [Related]
4. From cfDNA to Sequencing: Workflows and Potentials.
Tebaldi M; Salvi S
Methods Mol Biol; 2019; 1909():119-125. PubMed ID: 30580427
[TBL] [Abstract][Full Text] [Related]
5. Identification of liquid biopsy-based mutations in colorectal cancer by targeted sequencing assays.
Szász I; Kiss T; Mokánszki A; Koroknai V; Deák J; Patel V; Jámbor K; Ádány R; Balázs M
Mol Cell Probes; 2023 Feb; 67():101888. PubMed ID: 36513244
[TBL] [Abstract][Full Text] [Related]
6. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
Malapelle U; Mayo de-Las-Casas C; Rocco D; Garzon M; Pisapia P; Jordana-Ariza N; Russo M; Sgariglia R; De Luca C; Pepe F; Martinez-Bueno A; Morales-Espinosa D; González-Cao M; Karachaliou N; Viteri Ramirez S; Bellevicine C; Molina-Vila MA; Rosell R; Troncone G
Br J Cancer; 2017 Mar; 116(6):802-810. PubMed ID: 28170370
[TBL] [Abstract][Full Text] [Related]
7. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
[TBL] [Abstract][Full Text] [Related]
8. Development and Application of Duplex Sequencing Strategy for Cell-Free DNA-Based Longitudinal Monitoring of Stage IV Colorectal Cancer.
Mallampati S; Zalles S; Duose DY; Hu PC; Medeiros LJ; Wistuba II; Kopetz S; Luthra R
J Mol Diagn; 2019 Nov; 21(6):994-1009. PubMed ID: 31401123
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing.
Kang JK; Heo S; Kim HP; Song SH; Yun H; Han SW; Kang GH; Bang D; Kim TY
PLoS One; 2020; 15(5):e0232754. PubMed ID: 32379795
[TBL] [Abstract][Full Text] [Related]
10. Highly sensitive and specific real-time PCR by employing serial invasive reaction as a sequence identifier for quantifying EGFR mutation abundance in cfDNA.
Xiang Z; Wan R; Zou B; Qi X; Huang Q; Kumar S; Pitman JL; Zhou G; Song Q
Anal Bioanal Chem; 2018 Oct; 410(26):6751-6759. PubMed ID: 30128808
[TBL] [Abstract][Full Text] [Related]
11. Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients.
Zmrzljak UP; Košir R; Krivokapić Z; Radojković D; Nikolić A
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33669856
[TBL] [Abstract][Full Text] [Related]
12. Clonal diversity in KRAS mutant colorectal adenocarcinoma under treatment: Monitoring of cfDNA using reverse hybridization and DNA sequencing platforms.
Bádon ES; Mokánszki A; Mónus A; András C; Méhes G
Mol Cell Probes; 2023 Feb; 67():101891. PubMed ID: 36586518
[TBL] [Abstract][Full Text] [Related]
13. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
14. Cell-free DNA diagnostics: current and emerging applications in oncology.
Muluhngwi P; Valdes R; Fernandez-Botran R; Burton E; Williams B; Linder MW
Pharmacogenomics; 2019 Apr; 20(5):357-380. PubMed ID: 30983510
[TBL] [Abstract][Full Text] [Related]
15. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients.
Macías M; Cañada-Higueras E; Alegre E; Bielsa A; Gracia J; Patiño-García A; Ferrer-Costa R; Sendino T; Andueza MP; Mateos B; Rodríguez J; Corral J; Gúrpide A; Lopez-Picazo JM; Perez-Gracia JL; Gil-Bazo I; Alkorta-Aranburu G; González Á
Clin Chem Lab Med; 2020 Jul; 58(8):1341-1348. PubMed ID: 32623849
[TBL] [Abstract][Full Text] [Related]
16. Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing.
Mansukhani S; Barber LJ; Kleftogiannis D; Moorcraft SY; Davidson M; Woolston A; Proszek PZ; Griffiths B; Fenwick K; Herman B; Matthews N; O'Leary B; Hulkki S; Gonzalez De Castro D; Patel A; Wotherspoon A; Okachi A; Rana I; Begum R; Davies MN; Powles T; von Loga K; Hubank M; Turner N; Watkins D; Chau I; Cunningham D; Lise S; Starling N; Gerlinger M
Clin Chem; 2018 Nov; 64(11):1626-1635. PubMed ID: 30150316
[TBL] [Abstract][Full Text] [Related]
17. Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid.
Mehrotra M; Singh RR; Chen W; Huang RSP; Almohammedsalim AA; Barkoh BA; Simien CM; Hernandez M; Behrens C; Patel KP; Routbort MJ; Broaddus RR; Medeiros LJ; Wistuba II; Kopetz S; Luthra R
J Mol Diagn; 2017 Jul; 19(4):514-524. PubMed ID: 28506684
[TBL] [Abstract][Full Text] [Related]
18. Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study.
Alborelli I; Generali D; Jermann P; Cappelletti MR; Ferrero G; Scaggiante B; Bortul M; Zanconati F; Nicolet S; Haegele J; Bubendorf L; Aceto N; Scaltriti M; Mucci G; Quagliata L; Novelli G
Cell Death Dis; 2019 Jul; 10(7):534. PubMed ID: 31296838
[TBL] [Abstract][Full Text] [Related]
19. Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.
Wang JF; Pu X; Zhang X; Chen K; Xi Y; Wang J; Mao X; Zhang J; Heymach JV; Antonoff MB; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Meng QH; Shaw KR; Eterovic AK; Fang B
Cancer; 2018 Mar; 124(5):1061-1069. PubMed ID: 29178133
[TBL] [Abstract][Full Text] [Related]
20. Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer.
Strickler JH; Loree JM; Ahronian LG; Parikh AR; Niedzwiecki D; Pereira AAL; McKinney M; Korn WM; Atreya CE; Banks KC; Nagy RJ; Meric-Bernstam F; Lanman RB; Talasaz A; Tsigelny IF; Corcoran RB; Kopetz S
Cancer Discov; 2018 Feb; 8(2):164-173. PubMed ID: 29196463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
